Neurotropic & Cognitive
Semax / Selank
Peptide blend
Semax and Selank blend
Research context
This preparation combines Semax and Selank, two heptapeptides sharing the same C-terminal stabilisation strategy but derived from different parent sequences. Each is characterised independently in the published literature.
Common assays: Component identity by LC-MS · Purity per component
Specification
| Designation | Peptide blend |
|---|---|
| Full name | Semax and Selank blend |
| Components | Semax · Selank |
| Formats | 15 mL Nasal Spray · 15 mL Oral Spray |
| Solubility | Supplied in metered spray format |
| Storage | Refrigerated 2–8 °C |
| Current lot | SXS1515N1125 → |
Common questions
Can Semax and Selank be resolved chromatographically in a blend?
Yes — they differ in sequence and hydrophobicity sufficiently to separate under standard RP-HPLC conditions, allowing individual quantification.
Same pathway
Related compounds
Semax
ACTH(4-10) analog
A synthetic ACTH(4-10) analogue extended with Pro-Gly-Pro, studied in neurotrophic factor expression.
Selank
Tuftsin analog heptapeptide
A synthetic tuftsin analogue with a stabilising Pro-Gly-Pro extension, studied in GABAergic signalling.
DSIP
Delta sleep-inducing peptide
A nonapeptide first isolated from cerebral venous blood, studied in sleep architecture research.